The indication of ArriVent BioPharma shares at $20 on a volume of 82,000 shares suggests a specific price point but does not provide information on the direction of the price movement. Without additional context on whether this is higher or lower than previous close or the reasons behind the volume, the impact on the stock price is neutral in the short term.